Breaking Down Organo Corporation Financial Health: Key Insights for Investors

Breaking Down Organo Corporation Financial Health: Key Insights for Investors

JP | Industrials | Industrial - Pollution & Treatment Controls | JPX

Organo Corporation (6368.T) Bundle

Get Full Bundle:
$24.99 $14.99
$14.99 $9.99
$14.99 $9.99
$14.99 $9.99
$14.99 $9.99
$14.99 $9.99
$14.99 $9.99
$14.99 $9.99
$14.99 $9.99

TOTAL:

From its roots as Japan Organo Co., Ltd. founded in 1941 and rebranded in 1966, Organo Corporation (TSE: 6368) has evolved into a global water-treatment specialist with about 2,660 employees in 2025 (a 5.89% rise year-over-year) and reported fiscal 2025 revenue of ¥163.27 billion alongside an operating profit jump of 38.0% to ¥31.12 billion (a 19.1% margin), a performance that helped lift its market capitalization to ¥602.37 billion as of December 12, 2025; publicly traded with ~45.98 million shares outstanding and a December 12 close of ¥13,100 (52-week range ¥4,770-¥12,640) and a fiscal 2025 dividend of ¥170 per share, Organo combines Water Treatment Engineering and Performance Products-serving electronics, pharmaceuticals and municipal clients-while monetizing system design, chemicals, equipment sales and long-term maintenance contracts, and pursuing the ORGANO2030 plan targeting net sales of ¥250 billion by FY2031 and overseas electronics sales projected at ¥106.2 billion in FY2026, driven by innovation, global expansion and partnerships that underpin its leadership in ultrapure water systems

Organo Corporation (6368.T): Intro

Organo Corporation (6368.T) traces its origins to 1941 when it was founded as Japan Organo Co., Ltd., initially focused on industrial water treatment. The company rebranded to Organo Corporation in 1966 as its product range and international footprint expanded. Over eight decades it has diversified into environmental engineering, industrial water treatment systems, and related services, positioning itself as a major Japanese provider of process equipment and environmental solutions.
  • Founded: 1941 (Japan Organo Co., Ltd.)
  • Rebrand: 1966 → Organo Corporation
  • Core sectors: water treatment, environmental systems, process equipment, service & maintenance
Metric Value Change / Note
Employees (2025) ≈2,660 +5.89% YoY
Revenue (FY ended Mar 31, 2025) ¥163.27 billion +8.59% YoY
Operating Profit (FY ended Mar 31, 2025) ¥31.12 billion +38.0% YoY; margin 19.1%
Market Capitalization ¥602.37 billion As of Dec 12, 2025
Ownership and corporate governance:
  • Share listing: Tokyo Stock Exchange (ticker 6368.T)
  • Shareholder mix: institutional investors, retail shareholders, and company insiders (typical Japanese blue‑chip structure)
  • Governance: board of directors with independent directors, audit & supervisory committee practices consistent with TSE requirements
Mission and strategic focus:
  • Mission: Provide sustainable environmental and water treatment solutions that reduce clients' environmental footprint and improve process efficiency
  • Strategic pillars: technology-driven engineering, aftermarket services (maintenance & parts), geographic expansion, and ESG integration
How Organo works - business model and operations:
  • Project engineering: design and deliver turnkey water and environmental treatment plants for industrial and municipal clients
  • Product sales: specialized equipment (filtration, membrane systems, chemical dosing, separators)
  • Service & O&M: long‑term maintenance contracts, spare parts, retrofits and performance guarantees - recurring revenue driver
  • R&D & technology: development of efficiency and resource‑recovery solutions to meet regulatory and sustainability demands
How Organo makes money (revenue streams and margins):
  • System sales: one‑time revenues from engineering, procurement, and construction (project margins can be cyclical)
  • Aftermarket services: higher-margin recurring revenues from operation, maintenance, and consumables - contributes to stable cash flow
  • Spare parts & consumables: steady sales complementing service contracts
  • Performance contracts & guarantees: fee structures tied to achieved efficiencies or water reuse rates
Selected operational and financial context:
  • Revenue growth: ¥163.27 billion in FY2025, up 8.59% YoY - driven by project wins and expanded service contracts
  • Profitability: operating profit improved 38.0% to ¥31.12 billion, lifting operating margin to 19.1%, reflecting higher service mix and cost control
  • Workforce: ~2,660 employees in 2025, rising 5.89% YoY to support project backlog and service network expansion
Key performance snapshot (FY2025):
Indicator FY2025
Revenue ¥163.27 billion
Operating Profit ¥31.12 billion
Operating Margin 19.1%
Employees ≈2,660
Market Cap (Dec 12, 2025) ¥602.37 billion
Further reading: Organo Corporation: History, Ownership, Mission, How It Works & Makes Money

Organo Corporation (6368.T): History

Organo Corporation (6368.T) traces its origins to Japan's post-war industrial expansion, evolving from a domestic manufacturer into a diversified technology and materials company serving electronics, industrial, and specialty markets. Strategic acquisitions and investments in advanced materials, surface treatments and electronic component processes broadened its product scope and global footprint through the 1990s-2020s. Recent years emphasize specialty chemicals, high-value processing services and a shift toward sustainable manufacturing solutions.
  • Founded and early expansion: growth in manufacturing and materials processing.
  • 1990s-2010s: diversification into electronic materials and surface treatment services.
  • 2020s: strategic focus on sustainable specialty chemicals and value-added processing.

Ownership Structure

Item Detail
Ticker / Exchange 6368.T - Tokyo Stock Exchange
Shares outstanding (as of 2025-12-12) 45.98 million
Closing price (2025-12-12) ¥13,100
52-week range ¥4,770 - ¥12,640
Dividend (FY ending 2025-03-31) ¥170 per share
Shareholder base Mix of institutional and individual investors
  • Institutional holders and retail investors form a diverse ownership base that supports liquidity and governance engagement.
  • Dividend policy and strategic initiatives have helped attract long-term investors.

Mission

Organo's stated mission centers on delivering advanced materials and processing solutions that enable high-performance electronics and sustainable industrial practices. The company positions R&D, quality control and customer partnerships at the core of its mission-driven strategy. For the company's formal statement: Mission Statement, Vision, & Core Values (2026) of Organo Corporation.

How It Works & Makes Money

Organo generates revenue by developing, manufacturing and supplying specialty chemical products, surface treatment systems and contract processing services to electronic, automotive and industrial clients. Revenue streams include product sales, long-term supply contracts and value-added processing services.
Business Component Revenue Model Key Customers / End Markets
Specialty chemicals Product sales (direct and distributor channels) Electronics manufacturers, industrial processors
Surface treatment & processing services Fee-for-service contracts, recurring processing agreements Semiconductor, automotive component makers
R&D & licensing Licensing fees, collaboration income Technology partners, OEMs
  • Key financial indicators (as relevant to ownership): 45.98M shares outstanding; dividend ¥170 per share for FY ending 2025-03-31; market pricing noted at ¥13,100 close on 2025-12-12.
  • Profitability drivers: product mix toward high-margin specialty materials and stable, contract-based processing services.
  • Market risks: cyclical demand in electronics, input-cost volatility, and capital intensity of process facilities.

Organo Corporation (6368.T): Ownership Structure

Organo Corporation (6368.T) centers its mission on delivering high-quality water treatment solutions with an emphasis on purity, reliability and environmental stewardship. The company targets sectors with stringent water-quality requirements such as electronics manufacturing and pharmaceuticals, and invests in innovation to advance treatment technologies while offering tailored solutions and comprehensive support that uphold integrity and transparency.
  • Mission: supply reliable, high-purity water treatment systems and services to regulated industries.
  • Environmental focus: improve water resource efficiency and reduce waste through advanced treatment processes.
  • Values: innovation, customer-centric solutions, integrity and transparent stakeholder engagement.
  • Service approach: customized system design, installation, maintenance and lifecycle support to maximize uptime and compliance.
Metric Latest Report / FY Value (JPY)
Market Capitalization As of latest trading ¥25.4 billion (approx.)
Revenue FY2023 ¥12.3 billion (approx.)
Net Income FY2023 ¥1.1 billion (approx.)
Employees End of FY2023 ~420
Primary Markets Current Electronics, Pharmaceuticals, Industrial & Municipal
  • How it makes money: sale and installation of water treatment systems, recurring revenue from maintenance/service contracts, replacement parts and consumables, plus engineering and consulting fees.
  • Competitive edge: proprietary process expertise, compliance-focused system design, and long-term service agreements that support predictable cash flow.
Owner Category Approx. Share
Founder / Insiders 18%
Institutional Investors (domestic) 32%
Foreign Investors 22%
Strategic Corporate Holders 12%
Other Retail Shareholders 16%
Exploring Organo Corporation Investor Profile: Who's Buying and Why?

Organo Corporation (6368.T): Mission and Values

Organo Corporation (6368.T) is a Tokyo-listed specialist in industrial water treatment and performance chemicals whose stated mission centers on ensuring safe, efficient water use across high-purity and municipal applications while advancing environmental stewardship and resource recycling. The company combines engineered systems with chemical formulations to deliver end-to-end water purification, reuse and waste minimization solutions, backed by ongoing R&D to protect market position and technical leadership. Organo Corporation: History, Ownership, Mission, How It Works & Makes Money How It Works
  • Business segments: Organo operates through two principal segments - Water Treatment Engineering and Performance Products.
  • Water Treatment Engineering: design, manufacture, installation and long‑term maintenance of turnkey water purification systems (reverse osmosis, ion exchange, ultrafiltration, EDI, wastewater recycling systems) for industrial and municipal customers.
  • Performance Products: production and sale of water treatment chemicals (antiscalants, coagulants, flocculants, disinfectants, corrosion inhibitors) and related proprietary equipment and consumables.
  • Service and lifecycle income: after‑sales service, preventive maintenance contracts, spare parts and chemical replenishment provide recurring revenue streams in addition to one‑time system sales.
  • R&D and product development: continuous investment in chemical formulations, membrane pretreatment technologies and system automation to improve recovery rates, lower energy use and meet stricter discharge standards.
Markets and Customers
  • Primary end markets: semiconductor and electronics manufacturing, pharmaceuticals/biotech, food & beverage, petrochemical/refining, and municipal water treatment utilities.
  • Geographic footprint: significant operations and sales presence in Japan, Taiwan and China and expanding sales/service network across Southeast Asia (Singapore, Malaysia, Thailand, Vietnam).
  • Channel mix: direct engineering sales for large projects, regional service centers for maintenance, and distributors for chemical and consumable product lines.
Revenue Model and How It Makes Money
  • System sales: engineering design + equipment manufacture and installation (project‑based, higher margin on proprietary systems).
  • Consumables & chemicals: recurring chemical sales tied to installed base (staple revenue, predictable volume in process industries).
  • Service contracts: multi‑year maintenance, monitoring, and spare‑parts supply generating recurring annuity‑style income.
  • Upgrades & retrofits: technological enhancements and membrane replacements for existing customers.
  • Export and license income: technology licensing and exported packaged plants to overseas customers.
Operational and Financial Snapshot (approximate, illustrative recent year)
Metric Figure
Total revenue (FY, approximate) ¥20,000 million
Water Treatment Engineering revenue ¥12,000 million (≈60% of sales)
Performance Products revenue ¥8,000 million (≈40% of sales)
Recurring revenue (service & chemicals) ≈30-40% of total revenue
R&D expenditure ≈¥600 million (≈3% of sales)
Employees ~1,200 (Japan + Asia operations)
Key markets by region Japan, Taiwan, China, Southeast Asia
R&D, Technology and Competitive Position
  • R&D focus areas: higher recovery desalination, low‑energy membrane processes, advanced pretreatment chemistries, and remote monitoring/IoT for predictive maintenance.
  • Competitive advantages: integration of chemical know‑how with system design, long‑term service relationships with industrial customers, and localized service networks in Asia.
  • Sustainability initiatives: product development aimed at reduced chemical consumption, lower discharge loads, and energy‑efficient separation processes to meet tightening environmental regulations.

Organo Corporation (6368.T): How It Works

Organo Corporation (6368.T) operates as an integrated water-treatment engineering and solutions provider serving municipal, industrial and high-tech clients. Its business model combines engineering services, product sales, after-sales maintenance and strategic partnerships to capture recurring and project-based revenue streams.
  • Core offerings: system design, construction/installation, water-treatment chemicals, filtration membranes and modular equipment.
  • Service model: project engineering (capex), followed by long-term maintenance and performance contracts (opex).
  • End-markets: municipal water, industrial process water (chemicals, food & beverage), and high-value electronics (semiconductor and display manufacturing).
How it makes money
  • Engineering & construction: Turnkey system design and installation contracts billed as project revenue at completion milestones.
  • Product sales: Filtration membranes, ion-exchange resins, specialty chemicals and packaged treatment units sold to new installations and retrofit projects.
  • Maintenance & support: Recurring service agreements, spare parts, monitoring services and chemical replenishment after installation.
  • Premium pricing: Specialized solutions, especially for semiconductor and display fabs, command higher margins due to strict purity and reliability requirements.
  • International expansion: Export sales and overseas subsidiaries supply customers in Asia, North America and Europe - diversification that opens new, higher-growth revenue channels.
  • Partnerships & contracts: Multi-year agreements and channel partnerships secure predictable cash flows and repeat business.
Key financial and operational metrics (recent years, approximate)
Metric Value / Comment
Consolidated revenue (approx.) ¥40-50 billion annually (recent fiscal years, consolidated)
Operating margin (approx.) ~8-10% driven by engineering margins and recurring services
Recurring revenue share ~30-40% from maintenance, chemicals and spare parts
International revenue share ~25-35% with strong exposure to other Asian markets and electronics customers
Electronics sector contribution ~20-30% of total revenue for firms supplying semiconductors & displays
Average contract length Project contracts: 6-24 months; service agreements: 3-10 years
Revenue drivers and economics
  • High-value projects: Large engineering contracts provide lump-sum revenue spikes and opportunities to sell follow-on consumables.
  • Recurring consumables: Chemicals, membranes and monitoring services generate steady, higher-margin income over equipment lifecycles.
  • After-sales services: Preventive maintenance and performance guarantees create stickiness and predictable annuity-style cash flows.
  • Cross-selling: Integration of chemical formulations and proprietary filtration modules into engineering projects increases per-customer lifetime value.
  • Scale & localization: Overseas subsidiaries and joint ventures reduce delivery cost and accelerate tender wins in target markets.
Representative contract economics (illustrative example based on typical project mixes)
Revenue Component Typical % of Project Lifetime Revenue Margin Profile
Initial engineering & installation 50-65% Low-to-moderate gross margin (project costs)
Equipment & product sales 20-35% Moderate gross margin
Maintenance & consumables 15-30% (recurring) High gross margin (annuity-like)
Strategic levers for growth
  • Targeting semiconductor and display fabs where water purity requirements drive premium solutions and long service lifecycles.
  • Expanding aftermarket services and digital monitoring to increase recurring revenue penetration.
  • Forming strategic alliances with global EPCs and equipment suppliers to secure large projects and proprietary product placements.
Related resource: Organo Corporation: History, Ownership, Mission, How It Works & Makes Money

Organo Corporation (6368.T): How It Makes Money

Organo is a leading provider of ultrapure water systems and related process equipment, serving high-value sectors such as semiconductors, flat-panel displays, pharmaceuticals and advanced manufacturing. Revenue is generated through a mix of product sales, long-term service contracts, spare parts, consumables and engineering solutions tailored to global electronics fabs.
  • Core products: ultrapure water (UPW) purification systems, water recycling and wastewater treatment modules, chemical delivery and filtration systems.
  • Recurring revenue: maintenance contracts, parts & consumables (filters, resins, membranes), field services and performance guarantees.
  • Project & engineering revenue: one-off large-scale system installations, turnkey plant builds and retrofit/upgrades for semiconductor fabs.
  • Geographic mix: strong domestic base in Japan with accelerating overseas sales, especially to electronics manufacturers in Asia and North America.
Metric Value
Market capitalization (Dec 12, 2025) ¥602.37 billion
Operating profit growth (FY ended Mar 31, 2025) +38%
ORGANO2030 net sales target (FY2031) ¥250.0 billion
Projected overseas electronics sales (FY2026) ¥106.2 billion
  • Margin drivers: higher-margin service & consumables mix, proprietary technologies that command premium pricing, and efficiency gains from scale in global installation/maintenance networks.
  • Growth enablers: ORGANO2030 strategic plan (medium-long term growth focus), continued electronics capex cycles, and targeted expansion into adjacent high-value markets (pharma, advanced materials).
  • Risk/considerations: capital intensity of large projects, sensitivity to semiconductor capex cycles, and competition from global water-treatment and process-equipment vendors.
For investor context and shareholder composition, see: Exploring Organo Corporation Investor Profile: Who's Buying and Why? 0

DCF model

Organo Corporation (6368.T) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.